Molecubes Preclinical SPECT Imager
- Published
- 22 September 2025
- Estimated value
- £350,000
- Place of performance
- UKD
- Procedure
- Direct award
- Lots
- 1
- Notice number
- 058392-2025
- Reference
- ocds-h6vhtk-059ecc
- Official source
- Official source
CPV codes
- 38000000Laboratory, optical and precision equipments (excl. glasses)
Description
MDC's current imaging capabilities are limited to PET and CT, which restricts us to PET based tracers. While PET imaging is a powerful tool, it cannot accommodate a growing range of radioisotopes that are increasingly relevant in theranostic applications. These include lead 203, lead 212, lutetium 177, and actinium 225, which are essential for both diagnostic and therapeutic purposes. This limitation has become more pronounced as clinical and research interest in SPECT and CT imaging continues to grow. SPECT imaging enables biodistribution studies for isotopes that PET cannot support. This opens up new possibilities for molecular imaging and expands our ability to respond to evolving scientific and clinical needs. We have a clear opportunity to address this gap by introducing SPECT and CT capability through the phased procurement of the SPECT Cube module, followed by an upgrade to the advanced SPECT Cube 2.0 platform. This will allow MDC to meet rising diagnostic demand, align with industry standards, and maintain clinical competitiveness.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Southern Scientific Limited | £350,000 | — |
Official publications
- FTS · 058392-2025 · 22 September 2025
Other tenders from MEDICINES DISCOVERY CATAPULT LIMITED
- Consultant Recruitment
- Electronic Laboratory Notebook (ELN) and Laboratory Information Management System (LIMS)
- Financial Management System and Project management and Resourcing System
- Multiplex Biomarker Discover Equipment
- Planned Preventative Maintenance Contract
- Recruitment of Transition Lead Role for Medicines Discovery Catapult
- Lean SIx SIgma Consultancy for Medicines Discovery Catapult
- Gamma Counter for Medicines Discovery Catapult
- Online Webinar and Web Meeting Delivery Services for Medicines Discovery Catapult
- PACE Interim Impact Report
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £350,000.
- Who is the buyer of this tender?
- The contracting authority is MEDICINES DISCOVERY CATAPULT LIMITED (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.